Arjun Srinivasan, MD, from CDCgov, discusses the impact of COVID-19 on antimicrobial resistance.
This increase is a significant blow, representing at least 29,400 lives lost from antimicrobial-resistant infections commonly associated with healthcare. The overall burden of antimicrobial resistance is likely much higher, but the pandemic created data gaps.
Those of us who have the power to prescribe antibiotics and antifungals must remember: Any time these drugs are used, they can contribute to the development of resistance.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: